No-reflow phenomenon after acute myocardial infarction is associated with reduced clot permeability and susceptibility to lysis

Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2258-65. doi: 10.1161/ATVBAHA.107.149633. Epub 2007 Aug 2.

Abstract

Objective: We assessed the relationship between fibrin clot properties and the no-reflow phenomenon after primary coronary intervention (PCI).

Methods and results: Epicardial blood flow was assessed by TIMI scale and corrected TIMI frame count (cTFC), and perfusion by TIMI Myocardial Perfusion Grade (TMPG) after PCI during ST-segment elevation myocardial infarction (STEMI). Fibrin clot permeability (K(s)) and susceptibility to lysis in assays using exogenous thrombin (t(50%)) and without thrombin (t(TF)) were determined in 30 no-reflow patients (TIMI < or = 2) and in 31 controls (TIMI-3) after uneventful 6 to 14 months from PCI. Patients with TIMI < or = 2 had lower K(s) by 18% (P<0.0001) and prolonged fibrinolysis by 33% for t(50%) (P<0.0001) and by 45% for t(TF) (P<0.0001). cTFC was correlated with K(s) (r=-0.56, P<0.0001), t(50%) (r=0.49, P<0.001), and t(TF) (r=0.54, P<0.001). K(s) increased in a stepwise fashion with TIMI flow (P<0.0001) and TMPG (P<0.0001), whereas both fibrinolysis times decreased with TIMI flow (P<0.0001 for both) and TMPG (P<0.01 for both). Multiple regression models showed that only K(s) and fibrinogen were independent predictors of cTFC (P<0.05 for both), TIMI < or = 2 flow (P<0.05 for both) and TMPG-0/1 (P<0.05 for both).

Conclusions: Survivors of myocardial infarction with a history of the no-reflow after PCI are characterized with more compact fibrin network and its resistance to lysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Angioplasty, Balloon, Coronary / adverse effects*
  • Case-Control Studies
  • Coronary Angiography
  • Coronary Circulation*
  • Coronary Thrombosis / blood
  • Coronary Thrombosis / complications*
  • Coronary Thrombosis / physiopathology
  • Coronary Thrombosis / therapy
  • Electrocardiography
  • Female
  • Fibrin / metabolism
  • Fibrinolysis*
  • Follow-Up Studies
  • Humans
  • Linear Models
  • Male
  • Middle Aged
  • Myocardial Infarction / blood
  • Myocardial Infarction / etiology
  • Myocardial Infarction / physiopathology
  • Myocardial Infarction / therapy*
  • Permeability
  • Research Design
  • Risk Assessment
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome

Substances

  • Fibrin